AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

OTCMKTS:XCURExicure Stock Price, Forecast & News

$2.73
-0.06 (-2.15 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.67
Now: $2.73
$2.85
50-Day Range
$1.87
MA: $2.35
$2.77
52-Week Range
$0.96
Now: $2.73
$3.84
Volume263,342 shs
Average Volume279,447 shs
Market Capitalization$237.92 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.30 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:XCUR
CUSIPN/A
Phone(847) 673-1700

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees27
Market Cap$237.92 million
Next Earnings DateN/A
OptionableNot Optionable

Receive XCUR News and Ratings via Email

Sign-up to receive the latest news and ratings for XCUR and its competitors with MarketBeat's FREE daily newsletter.

Exicure (OTCMKTS:XCUR) Frequently Asked Questions

How has Exicure's stock been impacted by COVID-19 (Coronavirus)?

Exicure's stock was trading at $1.66 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, XCUR stock has increased by 64.5% and is now trading at $2.73. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Exicure?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exicure in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Exicure.

How were Exicure's earnings last quarter?

Exicure Inc (OTCMKTS:XCUR) announced its quarterly earnings results on Thursday, May, 14th. The company reported $0.01 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.10. The firm earned $9.18 million during the quarter, compared to analysts' expectations of $0.40 million. View Exicure's earnings history.

What price target have analysts set for XCUR?

3 analysts have issued 12-month price targets for Exicure's stock. Their forecasts range from $5.00 to $9.00. On average, they expect Exicure's share price to reach $7.33 in the next year. This suggests a possible upside of 168.6% from the stock's current price. View analysts' price targets for Exicure.

Has Exicure been receiving favorable news coverage?

Media stories about XCUR stock have been trending positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Exicure earned a daily sentiment score of 2.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutExicure.

Who are some of Exicure's key competitors?

What other stocks do shareholders of Exicure own?

Who are Exicure's key executives?

Exicure's management team includes the following people:
  • David A. Giljohann, Chief Executive Officer & Director
  • Matthias Schroff, Chief Operating Officer
  • David S. Snyder, Chief Financial Officer
  • Jocelyn Trokenheim, Vice President & Head-Business Developemnt

What is Exicure's stock symbol?

Exicure trades on the OTCMKTS under the ticker symbol "XCUR."

Who are Exicure's major shareholders?

Exicure's stock is owned by many different retail and institutional investors. Top institutional shareholders include Sphera Funds Management LTD. (3.77%), Geode Capital Management LLC (0.72%), BlackRock Inc. (0.38%), Asymmetry Capital Management L.P. (0.12%), Two Sigma Investments LP (0.11%) and State Street Corp (0.08%). Company insiders that own Exicure stock include Chad A Mirkin, David A Giljohann and David R Walt. View institutional ownership trends for Exicure.

Which institutional investors are selling Exicure stock?

XCUR stock was sold by a variety of institutional investors in the last quarter, including Asymmetry Capital Management L.P., and JPMorgan Chase & Co.. View insider buying and selling activity for Exicure.

Which institutional investors are buying Exicure stock?

XCUR stock was purchased by a variety of institutional investors in the last quarter, including Sphera Funds Management LTD., Geode Capital Management LLC, Two Sigma Investments LP, State Street Corp, Russell Investments Group Ltd., Two Sigma Advisers LP, Acadian Asset Management LLC, and Citigroup Inc.. Company insiders that have bought Exicure stock in the last two years include Chad A Mirkin, David A Giljohann, and David R Walt. View insider buying and selling activity for Exicure.

How do I buy shares of Exicure?

Shares of XCUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exicure's stock price today?

One share of XCUR stock can currently be purchased for approximately $2.73.

How big of a company is Exicure?

Exicure has a market capitalization of $237.92 million. Exicure employs 27 workers across the globe.

What is Exicure's official website?

The official website for Exicure is www.exicuretx.com.

How can I contact Exicure?

The company can be reached via phone at (847) 673-1700.

This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.